Effect of a 1-week treatment with 0.5% topical fluorouracil on occurrence of actinic keratosis after cryosurgery: A randomized, vehicle-controlled clinical trial

Archives of Dermatology

Volumn 140, Issue 7, 2004, Pages 813-816

  Jorizzo, Joseph ^a   Weiss, Jonathan ^b   Furst, Katharine ^c   VandePol, Christine ^c   Levy, Sharon F ^c  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b Gwinnett Clinical Research Center   (United States)

^c Dermik Laboratories   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL;

ACTINIC KERATOSIS; ADULT; AGED; ARTICLE; BURNING SENSATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREAM; CRYOSURGERY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRY SKIN; EDEMA; EROSION; ERYTHEMA; EYE IRRITATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PAIN; POSTOPERATIVE CARE; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SKIN MANIFESTATION; TREATMENT OUTCOME;

ADMINISTRATION, CUTANEOUS; ADULT; AGED; AGED, 80 AND OVER; ANTIMETABOLITES, ANTINEOPLASTIC; COMBINED MODALITY THERAPY; CRYOSURGERY; DOUBLE-BLIND METHOD; FACIAL DERMATOSES; FEMALE; FLUOROURACIL; HUMANS; KERATOSIS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; UNITED STATES;

EID: 3142692799     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.140.7.813     Document Type: Article

References (20)

1. American Cancer Society. Cancer Facts and Figures 2003. Available at: http://www.cancer.org/downloads/STT/CAFF2003PWSecured.pdf. Accessed April 3, 2003.
2. Glogau RG. The risk of progression to invasive disease. J Am Acad Dermatol. 2000;42(suppl):S23-S24.
3. Moy RL. Clinical presentation of actinic keratoses and squamous cell carcinoma. J Am Acad Dermatol. 2000;42(suppl):S8-S10.
4. Salache SJ. Epidemiology of actinic keratoses and squamous cell carcinoma. J Am Acad Dermatol. 2000;42(suppl):S4-S7.
5. Evans C, Cockerell CJ. Actinic keratosis: time to call a spade a spade. South Med J. 2000;93:734-736.
6. Committee on Guidelines of Care and Task Force on Actinic Keratoses. Guidelines of care for actinic keratoses. J Am Acad Dermatol. 1995;32:95-98.
7. Dinehart SM. The treatment of actinic keratoses. J Am Acad Dermatol. 2000;42 (suppl):S25-S28.
8. Lawrence N. New and emerging treatments for photoaging. Dermatol Clin. 2000;18:99-112.
9. Lubritz RR, Smolewski SA. Cryosurgery cure rate of actinic keratoses. J Am Acad Dermatol. 1982;7:631-632.
10. Dillaha CJ, Jansen GT, Honeycutt WM, Bradford AC. Selective cytotoxic effect of topical 5-fluorouracil. Arch Dermatol. 1963;88:247-256.
11. Dillaha CJ, Jansen GT, Honeycutt WM, Holt GA. Further studies with topical 5-fluorouracil. Arch Dermatol. 1965;92:410-417.
12. Breza T, Taylor R, Eaglstein W. Noninflammatory destruction of actinic keratoses by fluorouracil. Arch Dermatol. 1976;112:1256-1258.
13. Lawrence N, Cox SE, Cockerell CJ, Freeman RG, Cruz PD Jr. A comparison of the efficacy and safety of Jessner's solution and 35% trichloroacetic acid vs 5% fluorouracil in the treatment of widespread facial actinic keratoses. Arch Dermatol. 1995;131:176-181.
14. Levy S, Furst K, Chern W. A comparison of the skin permeation of three topical 0.5% fluorouracil formulations with that of a 5% formulation. Clin Ther. 2001;23:901-907.
15. Levy S, Furst K, Chern W. A pharmacokinetic evaluation of 0.5% and 5% fluorouracil topical cream in patients with actinic keratosis. Clin Ther. 2001;23:908-920.
16. Loven K, Stein L, Furst K, Levy S. Evaluation of the efficacy and tolerability of 0.5% fluorouracil cream and 5% fluorouracil cream applied to each side of the face in patients with actinic keratosis. Clin Ther. 2002;24:990-1000.
17. Jorizzo J, Stewart D, Bucko A, et al. Randomized trial evaluating a new 0.5% fluorouracil formulation demonstrates efficacy after 1 -, 2-, or 4-week treatment in patients with actinic keratosis. Cutis. 2002;70:335-339.
18. Weiss JW, Menter A, Hevia O, Jones T, Ling M, Rist T. Effective treatment of actinic keratosis with 0.5% fluorouracil cream for 1, 2, or 4 weeks. Cutis. 2002;70:22-29.
19. Graham GF. Cryosurgery. Clin Plast Surg. 1993;20:131-147.
20. Abadir DM. Combination of topical 5-fluorouracil with cryotherapy for treatment of actinic keratoses. J Dermatol Surg Oncol. 1983;9:403-404.